About Us

Rahul Chaudhary, MD, MBA
Founder & Director

image_edited_edited_edited_edited_edited

The Heart and Science Behind AI-HEART Lab

Philosophy: We focus on the integration of heart and mind, blending science with spirituality.
Founder's Background: Dr. Chaudhary possesses a diverse skill set, including roles as a physician, data scientist, software developer, and spiritual explorer.
Unique Problem-Solving Approach: Our approach is shaped by insights from various spiritual traditions, coupled with a deep understanding of psychology, physics, and mathematics.
Technologically Advanced & Humane Solutions: We strive to create solutions that are not only technologically advanced but also deeply considerate of human nature and needs.
Mission and Impact: We aim to make a meaningful difference in the lives of individuals, families, and communities, viewing challenges as opportunities for growth and wellbeing.

Biography

Dr. Rahul Chaudhary is an esteemed Cardiovascular Medicine Fellow at the University of Pittsburgh Medical Center Heart and Vascular Institute and holds a T32 Postdoctoral Research Fellowship with the National Institute of Health. His educational background is a testament to his interdisciplinary expertise, with a Master's in Intelligent Systems from the University of Pittsburgh.

Dr. Chaudhary's professional path is marked by significant achievements in both academia and entrepreneurial ventures. Before his current endeavors, he served as an Assistant Professor of Medicine at the Mayo Clinic and as an Academic Internal Medicine Hospitalist at Sinai Hospital of Baltimore. His entrepreneurial spirit is evident from his previous roles as a Co-founder and Chief Innovation and Strategy Officer, showcasing his ability to blend clinical insight with strategic innovation.

In the field of research, Dr. Chaudhary's focus areas include cardiovascular thrombosis, hemostasis, and the integration of artificial intelligence in medicine. He has contributed to over 100 peer-reviewed publications, achieving an impressive h-index of 20. Remarkably, all these accomplishments have been realized within a span of just eight years, highlighting his exceptional dedication and efficiency.

Philosophy

Dr. Chaudhary's philosophy is an intriguing fusion of Eastern wisdom and Western scientific inquiry, capturing the best of both worlds. He embodies Eastern philosophical principles in his daily life, complemented by an inquisitive Western mindset. This unique blend informs his approach to understanding and improving the human condition through medicine, research, and beyond.

He believes in the existence of four interconnected continuums: nature and its transformations, the living entity, the individual soul, and the supersoul. According to Dr. Chaudhary, it is through the interplay of these elements that physical reality manifests. His three core tenets - liberation from past influences, selfless service, and reducing suffering - converge to form a path to freedom and understanding.

In Dr. Chaudhary's view, these principles are not merely spiritual guideposts but also inform his holistic approach to life. His commitment extends from the pursuit of knowledge to its application in reducing human suffering, particularly in the fields of medicine and research. His work at AI-HEART Lab is a testament to his dedication to leveraging advanced technologies to enhance healthcare outcomes and understand the complexities of the human heart.

Research Publications

Peer-reviewed Articles

98. Singh S, Rout A, Chaudhary R, Garg A, Tantry US, Gurbel PA. Oxygen Targets After Cardiac Arrest: A Meta-analysis of Randomized Controlled Trials. Am J Ther. 2023 Nov-Dec 01;30(6):e509-e518. doi: 10.1097/MJT.0000000000001636. Epub 2023 Aug 17. PMID: 37921678.

97. Chaudhary R, Rajaratnam A, Harinstein ME. Hemodynamic Forces in Cardiac Resynchronization Therapy: Implications and Future Directions. Am J Cardiol. 2023 Oct 20:S0002-9149(23)01191-8. doi: 10.1016/j.amjcard.2023.10.036. Epub ahead of print. PMID: 37866450.

96. Singh S, Jain A, Goel S, Garg A, Chaudhary R, Tantry US, Gurbel PA. Role of Intravascular Imaging in Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2023 Oct 13;208:143-152. doi: 10.1016/j.amjcard.2023.09.070. Epub ahead of print. PMID: 37839171.

95. Singh S, Garg A, Chaudhary R, Rout A, Tantry US, Bliden K, Gurbel PA. Meta-analysis of immediate complete vs staged complete revascularization in patients with acute coronary syndrome and multivessel disease. Cardiovasc Revasc Med. 2023 Oct 6:S1553-8389(23)00835-7. doi: 10.1016/j.carrev.2023.10.005. Epub ahead of print. PMID: 37813709.

94. Chaudhary R, Rajaratnam A, Harinstein ME. Tumor Necrosis Factor-α Inhibitors in Cardiac Sarcoidosis Management: Evaluating Therapeutic Efficacy and Future Directions. Am J Cardiol. 2023 Sep 5:S0002-9149(23)00850-0. doi: 10.1016/j.amjcard.2023.08.085. Epub ahead of print. PMID: 37679194.

93. Chaudhary R, Harinstein ME. Leveraging Artificial Intelligence in Cardiology: Interaction Between Atrial Fibrillation and Cardiopulmonary Dynamics. Am J Cardiol. 2023 Sep 5:S0002-9149(23)00847-0. doi: 10.1016/j.amjcard.2023.08.081. Epub ahead of print. PMID: 37679192.

92. Singh S, Goel S, Duhan S, Chaudhary R, Garg A, Tantry US, Gurbel PA. Effect of Furosemide Versus Torsemide on Hospitalizations and Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2023 Sep 5;206:42-48. doi: 10.1016/j.amjcard.2023.08.079. Epub ahead of print. PMID: 37677884.

91. Singh S, Goel S, Chaudhary R, Garg A, Tantry US, Gurbel PA, Garg L. Safety and Effectiveness of Adjunctive Posterior Wall Isolation in Atrial Fibrillation Patients: An Updated Meta-Analysis. Am J Cardiol. 2023 Sep 15;203:64-72. doi: 10.1016/j.amjcard.2023.06.116. Epub 2023 Jul 21. PMID: 37481814.

90. Singh S, Goel S, Chaudhary R, Garg A, Tantry US, Gurbel PA, Garg L. Safety and Effectiveness of Adjunctive Posterior Wall Isolation in Atrial Fibrillation Patients: An Updated Meta-Analysis. Am J Cardiol. 2023 Sep 15;203:64-72. doi: 10.1016/j.amjcard.2023.06.116. Epub 2023 Jul 21. PMID: 37481814.

89. Kingsley R, Rohlman C, Otto A, Chaudhary R, Phelan D, Kirchoff R. Remdesivir-induced conduction abnormalities: A molecular model-based explanation. Journal of Pharmacy & Pharmaceutical Sciences. 2023;26.

88. Kingsley R, Rohlman C, Chaudhary R, Phelan D, Kirchoff R. Cardiac Conduction Delay Associated With Remdesivir in COVID-19. Journal of Contemporary Pharmacy Practice. 2022;69(4):13-16.

87. Chaudhary R, Neal MD. Invited Commentary: Platelet and Clot Characteristics to Guide Antithrombotic Management in Patients with Polyvascular Disease. J Am Coll Surg. 2023 Mar 1;236(3):504-505. doi: 10.1097/XCS.0000000000000493. Epub 2022 Dec 9. PMID: 36729750.

86. Chaudhary R, Singh A, Chaudhary R, Bashline M, Houghton DE, Rabinstein A, Adamski J, Arndt R, Ou NN, Rudis MI, Brown CS, Wieruszewski ED, Wanek M, Brinkman NJ, Linderbaum JA, Sorenson MA, Atkinson JL, Thompson KM, Aiyer AN, McBane RD 2nd. Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022 Nov 1;5(11):e2240145. doi: 10.1001/jamanetworkopen.2022.40145. PMID: 36331504.

85. Chaudhary R, Bashline M, Novelli EM, Bliden KP, Tantry US, Olafiranye O, Nouraie SM, Gurbel PA, Pacella JJ. Reply to: Among patients with MINOCA women versus men have the increased risks of MACE and stroke? Int J Cardiol. 2022 Oct 7:S0167-5273(22)01473-5. doi: 10.1016/j.ijcard.2022.10.005. Epub ahead of print. PMID: 36209769.

84. Chaudhary R, Sharma T, Tantry US, Asgar JA, Kundan P, Duhan S, Gill H, Singh A, Alasadi Y, Gurbel PA, Bliden KP. Serial assessment of thrombogenicity and hemodynamics in patients with type II diabetes in a clinical research unit: Evidence for circadian variations in clot formation. J Thromb Thrombolysis. 2022 Sep 8. doi: 10.1007/s11239-022-02699-1. Epub ahead of print. PMID: 36074227.

83. Chaudhary R, Bashline M, Novelli EM, Bliden KP, Tantry US, Olafiranye O, Rahman A, Gurbel PA, Pacella JJ. Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis. Int J Cardiol. 2022 Aug 1:S0167-5273(22)01120-2. doi: 10.1016/j.ijcard.2022.07.050. Epub ahead of print. PMID: 35926644.

82. Bashline MJ, Chaudhary R, Wong TC, Okonkwo DO, Aiyer A. Examining the Duration and Safety of Withholding Anticoagulation After an Intracerebral Hemorrhage in Patients With Mechanical Heart Valves. Am J Cardiol. 2022 Aug 15;177:164-166. doi: 10.1016/j.amjcard.2022.05.008. Epub 2022 Jun 25. PMID: 35764429.

81. Singh A, Verma V, Chaudhary R. Direct Oral Anticoagulants Associated Hemopericardium. Jan 7, 2021. https://www.acc.org/latest-in-cardiology/articles/2021/01/06/20/26/direct-oral-anticoagulants-associated-hemopericardium

80. Chaudhary R, Ajibawo T, Kirchoff R, Turagam M, Lakkireddy D, Garg J. Preventing Atrial Fibrillation in Patients After Coronary Artery Bypass Grafting, American Journal of Therapeutics: April 7, 2021 - Volume - Issue - doi: 10.1097/MJT.0000000000001352

79. Sarkar S, Rapista N, Rout A, Chaudhary R. BRASH: Case Report and Review of Literature. Hearts. 2021; 2(3):302-306. https://doi.org/10.3390/hearts2030025

78. Chaudhary R, Loganathan D, Vlazny DT, Casanegra AI, Houghton DE, Froehling DA, Peterson LG, Hodge DO, McBane RD 2nd, Wysokinski WE. Demographics and Clinical Outcomes in Patients Older Than 75 Years Treated for Acute Venous Thromboembolism. Am J Ther. 2021 Jun 11;29(1):e151-e153. doi: 10.1097/MJT.0000000000001389. PMID: 34994355.

77. Shah K, Chaudhary R, K Turagam M, Shah M, Patel B, Lanier G, Lakkireddy D, Garg J. Active Implantable cardioverter-defibrillators in Continuous-flow Left Ventricular Assist Device Recipients. J Atr Fibrillation. 2021 Jun 30;14(1):20200490. doi: 10.4022/jafib.20200490. PMID: 34950365; PMCID: PMC8691323.

76. Pasha AK, McBane RD, Chaudhary R, Padrnos LJ, Wysokinska E, Pruthi R, Ashrani A, Daniels P, Sridharan M, Wysokinski WE, Houghton DE. Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19. Thromb Res. 2021 Oct 7;207:150-157. doi: 10.1016/j.thromres.2021.09.021. Epub ahead of print. PMID: 34649175; PMCID: PMC8495042.

75. Chaudhary R, Sukhi A, Simon MA, Villanueva FS, Pacella JJ. Role of Internal Jugular Venous Ultrasound in suspected or confirmed Heart Failure: A Systematic Review. J Card Fail. 2021 Aug 19:S1071-9164(21)00346-8. doi: 10.1016/j.cardfail.2021.08.009. Epub ahead of print. PMID: 34419599.

74. Chaudhary R, Padrnos L, Wysokinska E, Pruthi R, Misra S, Sridharan M, Wysokinski W, McBane RD 2nd, Houghton DE. Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients. Mayo Clin Proc. 2021 Jul;96(7):1718-1726. doi: 10.1016/j.mayocp.2021.04.022. Epub 2021 May 4. PMID: 34218854; PMCID: PMC8096191.

73. Chadha M, Dunne AM, Rodriguez N, Chaudhary R. COVID-19 and clinic workflow optimization using lean six sigma. Am J Manag Care. 2021 Jun;27(6):225-226. doi: 10.37765/ajmc.2021.88661. PMID: 34156214.

72. Kirchoff RW, Mohammed NM, McHugh J, Markota M, Kingsley T, Leung J, Burton MC, Chaudhary R. Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr 8;5(2):495-501. doi: 10.1016/j.mayocpiqo.2021.01.013. PMID: 33997645; PMCID: PMC8105524.

71. Gurbel PA, Bliden KP, Rout A, Rapista N, Walia N, Chaudhary R, Ens G, Traianova M, Barnes JS, Tantry US. Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population. J Thromb Thrombolysis. 2021 May;51(4):902-904. doi: 10.1007/s11239-021-02435-1. Epub 2021 Apr 7. PMID: 33826054; PMCID: PMC8024672.

70. Chaudhary R, Mohananey A, Sharma SP, Singh S, Singh A, Kondur A. Improving Outcomes in Cardiovascular Diseases: A Review on Vorapaxar. Cardiol Rev. 2021 Mar 19. doi: 10.1097/CRD.0000000000000390. Epub ahead of print. PMID: 33758122.

69. Chaudhary R, Garg J, Houghton DE, Murad MH, Kondur A, Chaudhary R, Wysokinski WE, McBane RD 2nd. Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr;5(2):388-402. doi: 10.1016/j.mayocpiqo.2021.01.009. Epub 2021 Feb 8. PMID: 33585800; PMCID: PMC7869679.

68. Kirchoff RW, Tata B, McHugh J, Kingsley T, Burton MC, Manning D, Lapid M, Chaudhary R. Spiritual Care of Inpatients Focusing on Outcomes and the Role of Chaplaincy Services: A Systematic Review. J Relig Health. 2021 Apr;60(2):1406-1422. doi: 10.1007/s10943-021-01191-z. Epub 2021 Feb 11. Erratum in: J Relig Health. 2021 Jun;60(3):2190. PMID: 33575891.

67. Kant R, Verma V, Patel S, Chandra R, Chaudhary R, Shuldiner AR, Munir KM. Effect of serum zinc and copper levels on insulin secretion, insulin resistance and pancreatic β cell dysfunction in US adults: Findings from the National Health and Nutrition Examination Survey (NHANES) 2011-2012. Diabetes Res Clin Pract. 2021 Feb;172:108627. doi: 10.1016/j.diabres.2020.108627. Epub 2020 Dec 15. PMID: 33333205.

66. Chaudhary R, Bliden KP, Kreutz RP, Jeong YH, Tantry US, Levy JH, Gurbel PA. Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations. EClinicalMedicine. 2020 Dec;29:100647. doi: 10.1016/j.eclinm.2020.100647. Epub 2020 Nov 20. PMID: 33251501; PMCID: PMC7678450.

65. Chaudhary R, Kingsley T, Sarkar S, Carrington J, Sanchez Palacios GM, Sharma T, Garg J, Chaudhary R. Telemetry: appropriateness of initial assignment and duration in nonintensive setting. Am J Manag Care. 2020 Nov;26(11):459-460. doi: 10.37765/ajmc.2020.88524. PMID: 33196277.

64. Mohananey D, Mewhort H, Shekhar S, Mohananey A, Chaudhary R, Gaglianello N, Ramakrishna H. Heart Failure Trial Update-Analysis of Recent Data. J Cardiothorac Vasc Anesth. 2020 Sep 7:S1053-0770(20)30951-4. doi: 10.1053/j.jvca.2020.09.085. Epub ahead of print. PMID: 33039289.

63. Gurbel PA, Bliden KP, Chaudhary R, Tantry US. First In-Human Experience With Inhaled Acetylsalicylic Acid for Immediate Platelet Inhibition: Comparison With Chewed and Swallowed Acetylsalicylic Acid. Circulation. 2020 Sep 29;142(13):1305-1307. doi: 10.1161/CIRCULATIONAHA.120.047477. Epub 2020 Sep 28. PMID: 32986482.

62. Sharma SP, Chaudhary R, Ghuneim A, Harder W, David S, Choksi N, Kondur S, Kambhatla S, Kambhatla S, Kondur A. Carotid access for transcatheter aortic valve replacement: A meta-analysis. Catheter Cardiovasc Interv. 2020 Sep 5. doi: 10.1002/ccd.29244. Epub ahead of print. PMID: 32890443.

61. Jeong YH, Kevin B, Ahn JH, Chaudhary R, Kang MG, Park HW, Koh JS, Park Y, Tantry US, Gurbel PA. Viscoelastic properties of clot formation and their clinical impact in East Asian versus Caucasian patients with stable coronary artery disease: a COMPARE-RACE analysis. J Thromb Thrombolysis. 2020 Aug 27. doi: 10.1007/s11239-020-02240-2. Epub ahead of print. PMID: 32852671.

60. Chaudhary R, Kreutz RP, Bliden KP, Tantry US, Gurbel PA. Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry. Thromb Haemost. 2020 Jul 17. doi: 10.1055/s-0040-1714217. Epub ahead of print. PMID: 32679595.

59. Sherwood M, Bliden KP, Ilkhanoff L, Venkataraman G, Strickberger A, Yazdani S, McSwain R, Rashid H, Navarese EP, Plummer T, Batchelor W, Chaudhary R, Tantry US, Gurbel PA. Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case-control study. J Thromb Thrombolysis. 2020 Jun 29 Epub 2020 June 29. PMID: 32601850 DOI: 10.1007/s11239-020-02205-5.

58. Rapista N, Sarkar S, Chaudhary R. Rivaroxaban-induced hemorrhagic pericardial tamponade in end-stage renal disease. J Thromb Thrombolysis 2020 Jun 3 Epub 2020 June 03 PMID: 32495012 DOI: 10.1007/s11239-020-02164-x

57. Chaudhary R, Pagali S, Garg J, Murad MH, Wysokinski WE, McBane RD 2nd. DOACs Versus VKAs in Older Adults Treated for Acute Venous Thromboembolism: Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2020 May 22 [Epub ahead of print] PMID: 32441334 DOI: 10.1111/jgs.16549

56. Sharma T, Chaudhary R, Garg J, Kondur A, Mohananey D, Chaudhary R. Six sigma approach to reduce door-to-balloon time for patients with STEMI. Am J Manag Care. 2020 May 1; 26 (5):e140-e141 Epub 2020 May 01 PMID: 32436681 DOI: 10.37765/ajmc.2020.43155

55. Novakovic M, Rout A, Kingsley T, Kirchoff R, Singh A, Verma V, Kant R, Chaudhary R. Role of gut microbiota in cardiovascular diseases. World J Cardiol. 2020 Apr 26; 12 (4):110-122 PMID: 32431782 PMCID: 7215967 DOI: 10.4330/wjc.v12.i4.110

54. Tantry US, Bliden KP, Chaudhary R, Novakovic M, Rout A, Gurbel PA. Vorapaxar in the treatment of cardiovascular diseases. Future Cardiol. 2020 Apr 20 [Epub ahead of print] PMID: 32308016 DOI: 10.2217/fca-2019-0090

53. Sharma SP, Chaudhary R, Gupta P, Kondur S, Gatla N, Blaceri S, Choksi N, Kassab E, Sareen N, Kondur A. Baseline thrombocytopenia in women with coronary heart disease increases incident acute coronary syndrome: insights from national inpatient database. J Thromb Thrombolysis. 2020 Apr 6 Epub 2020 Apr 06 PMID: 32253707 DOI: 10.1007/s11239-020-02096-6

52. Chaudhary R, Kirchoff R, Kingsley T, Newman JS, Houghton DE, McBane RD 2nd. Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization. Mayo Clin Proc Innov Qual Outcomes. 2020 Apr; 4 (2):170-175 Epub 2020 Mar 18 PMID: 32280927 PMCID: 7140011 DOI: 10.1016/j.mayocpiqo.2019.12.004

51. Kingsley T, Kirchoff R, Newman JS, Chaudhary R. Demystifying airline syncope. World J Cardiol. 2020 Mar 26; 12 (3):107-109 PMID: 32280429 PMCID: 7138867 DOI: 10.4330/wjc.v12.i3.107

50. Chaudhary R, Garg J. His bundle pacing in heart failure: A review of current literature Journal of Cardiology and Cardiovascular Medicine. 2020; 5:042-046. DOI: 10.29328/journal.jccm.1001084

49. Chaudhary R, Sharma T, Garg J, Sukhi A, Bliden K, Tantry U, Turagam M, Lakkireddy D, Gurbel P. Direct oral anticoagulants: a review on the current role and scope of reversal agents. J Thromb Thrombolysis. 2020 Feb; 49 (2):271-286 PMID: 31512202 DOI: 10.1007/s11239-019-01954-2

48. Rout A, Sukhi A, Chaudhary R, Bliden KP, Tantry US, Gurbel PA. Investigational drugs in phase II clinical trials for acute coronary syndromes. Expert Opin Investig Drugs. 2020 Jan; 29 (1):33-47 Epub 2020 Jan 03 PMID: 31869253 DOI: 10.1080/13543784.2020.1708324

47. Bliden K, Chaudhary R, Kuliopulos A, Tran H, Taheri H, Tehrani B, Rosenblatt A, Navarese E, Tantry US, Gurbel PA. Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono- and dual-antiplatelet therapy. J Thromb Haemost. 2020 Jan; 18 (1):23-35 Epub 2019 Sept 17 PMID: 31444884 PMCID: 6940524 DOI: 10.1111/jth.14616

46. Garg J, Gupta R, Chaudhary R, Gupta R, Patel RN, Turagam M, Gupta HB, Neki NS. Magnetic Versus Manual Catheter Navigation for Ablation of VentricularTachycardia: A Systemic Review and Meta-Analysis Asian Journal of Medical Research. 2019; 8(4). DOI: 10.21276/ajmr.2019.8.4.ME1

45. Chaudhary R, Sukhi A, Chaudhary R, Jindal M, Vyas A, Rout A, Bliden K, Tantry U, Gurbel P. Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease. J Thromb Thrombolysis. 2019 Oct; 48 (3):373-381 PMID: 31218482 DOI: 10.1007/s11239-019-01901-1

44. Tantry US, Chaudhary R, Gurbel PA. In search for an optimal antithrombotic regimen in patients with atrial fibrillation undergoing stenting. Kardiol Pol 2019 Sep 23; 77 (9):817-819 Epub 2019 Sept 23 PMID: 31544895 DOI: 10.33963/KP.14983

43. Garg J, Patel B, Chaudhary R, Shah M, Gupta R, Gunda S, Padala SK, Ellenbogen KA. Predictors of 30-day readmissions after catheter ablation for atrial fibrillation in the USA. J Interv Card Electrophysiol. 2019 Sep; 55 (3):243-250 Epub 2019 Jan 05 PMID: 30612212 DOI: 10.1007/s10840-018-0503-3

42. Wang L, Alammar N, Singh R, Nanavati J, Song Y, Chaudhary R, Mullin GE. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. J Acad Nutr Diet. 2019 Aug 28 [Epub ahead of print] PMID: 31473156 DOI: 10.1016/j.jand.2019.05.015

41. Chaudhary R, Rout A, Jindal M, Vyas A, Bliden K, Tantry U, Gurbel PA. 21 Restenosed Stents in the Prescence of Adequate P2Y 12 Inhibition: A Case Report Biomedical Journal of Scientific & Technical Research. 2019; 18(1):13195-13198.

40. Chaudhary R, Garg J, Turagam M, Chaudhary R, Gupta R, Nazir T, Bozorgnia B, Albert C, Lakkireddy D. Role of Prophylactic Magnesium Supplementation in Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting: a Systematic Review and Meta-Analysis of 20 Randomized Controlled Trials. J Atr Fibrillation. 2019 Jun; 12 (1):2154 Epub 2019 June 30 PMID: 31687067 PMCID: 6811340 DOI: 10.4022/jafib.2154

39. Damluji AA, Bandeen-Roche K, Berkower C, Boyd CM, Al-Damluji MS, Cohen MG, Forman DE, Chaudhary R, Gerstenblith G, Walston JD, Resar JR, Moscucci M. Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock. J Am Coll Cardiol. 2019 Apr 23; 73 (15):1890-1900 PMID: 30999991 PMCID: 7185801 DOI: 10.1016/j.jacc.2019.01.055

38. Bliden KP, Raviv G, Tantry US, Chaudhary R, Cochran JW, Navarese EP, Brannan T, Vyas A, Gurbel PA. "Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke. J Thromb Thrombolysis. 2019 Feb; 47 (2):192-199 PMID: 30673942 DOI: 10.1007/s11239-019-01813-0

37. Chaudhary R, Kinderyte M, Chaudhary R, Sukhi A, Bliden K, Tantry U, Gurbel P. HDL3-C is a marker of coronary artery disease severity and inflammation in patients on statin therapy. Cardiovasc Revasc Med. 2018 Dec 27 [Epub ahead of print] PMID: 30626544 DOI: 10.1016/j.carrev.2018.12.019

36. Chaudhary R, Tantry U, Price MJ, Gurbel PA. Immediate P2Y12 inhibition in the current era of percutaneous intervention. acc.org/education-and-meetings/patient-case-quizzes/2018/10/23/07/06/immediate- p2y12-inhibition-in-the-current-era-of-percutaneous-intervention.. 2018.

35. Tantry U, Chaudhary R, Kubica J, Bliden K, Gurbel PA. Cangrelor for the treatment of patients with Arterial Thrombosis. Expert Opin Pharmacother. 2018 Aug; 19 (12):1389-1398 Epub 2018 Aug 13 PMID: 30102083 DOI: 10.1080/14656566.2018.1506767

34. Patel B, Garg J, Chaudhary R, Sablani N, Gupta R, Shah M, Nazir T, Bozorgnia B, Natale A. His Bundle Pacing: Hemodynamics and Clinical Outcomes. Cardiol Rev. 2018 Jul/Aug; 26 (4):201-206 PMID: 29608497 DOI: 10.1097/CRD.0000000000000191

33. Patel B, Sablani N, Garg J, Chaudhary R, Shah M, Gupta R, Nazir T, Bozorgnia B, Padala SK, Gunda S, Ellenbogen KA. Thirty-day readmissions after cardiac implantable electronic devices in the United States: Insights from the Nationwide Readmissions Database. Heart Rhythm. 2018 May; 15 (5):708-715 Epub 2018 Jan 06 PMID: 29317316 DOI: 10.1016/j.hrthm.2018.01.006

32. Tantry US, Navarese EP, Myat A, Chaudhary R, Gurbel PA. Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments. Expert Opin Pharmacother. 2018 May; 19 (7):653-665 Epub 2018 Apr 11 PMID: 29611444 DOI: 10.1080/14656566.2018.1457649

31. Chaudhary R, Tantry U, Bliden K, Price MJ, Gurbel PA. Use of Intravenous Antiplatelet Agents (Cangrelor and GPIIb/IIIa Inhibitors) in the Modern Era. Jan 30, 2018. https://www.acc.org/latest-in-cardiology/articles/2018/01/30/08/11/use-of-intravenous-antiplatelet-agents-in-the-modern-era

30. Bliden KP, Chaudhary R, Navarese EP, Sharma T, Kaza H, Tantry US, Gurbel PA. Thrombogenicity and central pulse pressure to enhance prediction of ischemic event occurrence in patients with established coronary artery disease: The MAGMA-ischemia score. Atherosclerosis. 2018 Jan; 268:55-62 Epub 2017 Nov 20 PMID: 29175655 DOI: 10.1016/j.atherosclerosis.2017.11.018

29. Chaudhary R, Garg J, Krishnamoorthy P, Bliden K, Shah N, Agarwal N, Gupta R, Sharma A, Kern KB, Patel NC, Gurbel P. Erythropoietin therapy after out-of-hospital cardiac arrest: A systematic review and meta-analysis. World J Cardiol. 2017 Dec 26; 9 (12):830-837 PMID: 29317989 PMCID: 5746625 DOI: 10.4330/wjc.v9.i12.830

28. Chaudhary R, Damluji A, Batukbhai B, Sanchez M, Feng E, Chandra Serharan M, Moscucci M. Venous Thromboembolism Prophylaxis: Inadequate and Overprophylaxis When Comparing Perceived Versus Calculated Risk. Mayo Clin Proc Innov Qual Outcomes. 2017 Dec; 1 (3):242-247 Epub 2017 Dec 01 PMID: 30225423 PMCID: 6132201 DOI: 10.1016/j.mayocpiqo.2017.10.003

27. Chaudhary R, Mathew D, Bliden K, Tantry US, Sharma T, Gesheff MG, Franzese CJ, Pandya S, Toth PP, Gurbel PA. Low-density lipoprotein 4: a novel predictor of coronary artery disease severity. Curr Med Res Opin. 2017 Nov; 33 (11):1979-1984 Epub 2017 Sept 01 PMID: 28787217 DOI: 10.1080/03007995.2017.1365052

26. Gupta N, Chaudhary R, Krishnamoorthy P, Mahajan S, Bodin R, Sule S. Coronary Artery Disease in Patients With Disorders of Bilirubin Excretion. Am J Ther. 2017 Nov/Dec; 24 (6):e653-e658 PMID: 26448335 DOI: 10.1097/MJT.0000000000000343

25. Romero J, Chaudhary R, Garg J, Lupercio F, Shah N, Gupta R, Nazir T, Bozorgnia B, Natale A, Di Biase L. Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials. J Interv Card Electrophysiol. 2017 Sep; 49 (3):263-270 Epub 2017 July 03 PMID: 28674918 DOI: 10.1007/s10840-017-0260-8

24. Garg J, Chaudhary R, Shah N, Palaniswamy C, Bozorgnia B, Nazir T, Natale A, Kutyifa V. Right ventricular apical versus non-apical implantable cardioverter defibrillator lead: A systematic review and meta-analysis. J Electrocardiol. 2017 Sep - Oct; 50 (5):591-597 Epub 2017 May 18 PMID: 28554513 DOI: 10.1016/j.jelectrocard.2017.05.003

23. Rouf R, MacFarlane EG, Takimoto E, Chaudhary R, Nagpal V, Rainer PP, Bindman JG, Gerber EE, Bedja D, Schiefer C, Miller KL, Zhu G, Myers L, Amat-Alarcon N, Lee DI, Koitabashi N, Judge DP, Kass DA, Dietz HC. Nonmyocyte ERK1/2 signaling contributes to load-induced cardiomyopathy in Marfan mice. JCI Insight. 2017 Aug 3; 2 (15) Epub 2017 Aug 03 PMID: 28768908 PMCID: 5543913 DOI: 10.1172/jci.insight.91588

22. Chen G, Bliden KP, Chaudhary R, Liu F, Kaza H, Navarese EP, Tantry US, Gurbel PA. Central aortic pulse pressure, thrombogenicity and cardiovascular risk. J Thromb Thrombolysis. 2017 Aug; 44 (2):223-233 PMID: 28695310 DOI: 10.1007/s11239-017-1524-y

21. Shah N, Agarwal V, Chaudhary R, Garg J, Kern KB, Patel NC. Risk of stent thrombosis in patients with AMI and cardiac arrest treated with hypothermia - expert analysis. acc.org/latest-in-cardiology/articles/2017/07/25/14/30/risk-of-stent-thrombosis-in-patients- with-ami-and-cardiac-arrest-treated-with-hypothermia. 2017.

20. Bliden KP, Chaudhary R, Mohammed N, Muresan AA, Lopez-Espina CG, Cohen E, Raviv G, Doubleday M, Zaman F, Mathew B, Tantry US, Gurbel PA. Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system. J Thromb Thrombolysis. 2017 May; 43 (4):437-445 PMID: 28247290 DOI: 10.1007/s11239-017-1477-1

19. Chaudhary R, Garg J, Krishnamoorthy P, Shah N, Feldman BA, Martinez MW, Freudenberger R. On-X Valve: The Next Generation Aortic Valve. Cardiol Rev. 2017 Mar/Apr; 25 (2):77-83 PMID: 28170357 DOI: 10.1097/CRD.0000000000000105

18. Chaudhary R, Garg J, Shah N, Sumner A. PCSK9 inhibitors: A new era of lipid lowering therapy. World J Cardiol. 2017 Feb 26; 9 (2):76-91 PMID: 28289523 PMCID: 5329749 DOI: 10.4330/wjc.v9.i2.76

17. Shah N, Chaudhary R, Mehta K, Agarwal V, Garg J, Freudenberger R, Jacobs L, Cox D, Kern KB, Patel N. Reply: Do We Need Individualized Therapeutic Strategies in High-Risk Patients Treated With Hypothermia? JACC Cardiovasc Interv 2017 Jan 9; 10 (1):105-106 PMID: 28057280 DOI: 10.1016/j.jcin.2016.11.015

16. Sharma T, Bliden K, Chaudhary R, Tantry U, Gurbel PA. Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease. Expert Opin Pharmacother. 2017 Jan; 18 (1):123-131 PMID: 27937054 DOI: 10.1080/14656566.2016.1269747

15. Gurbel PA, Bliden KP, Chaudhary R, Patrick J, Liu F, Chen G, McLeod C, Tantry US. Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus. Am J Cardiol. 2016 Dec 15; 118 (12):1941-1947 Epub 2016 Sept 20 PMID: 27769511 DOI: 10.1016/j.amjcard.2016.08.088

14. Gupta N, Singh T, Chaudhary R, Garg SK, Sandhu GS, Mittal V, Gupta R, Bodin R, Sule S. Bilirubin in coronary artery disease: Cytotoxic or protective? World J Gastrointest Pharmacol Ther. 2016 Nov 6; 7 (4):469-476 PMID: 27867680 PMCID: 5095566 DOI: 10.4292/wjgpt.v7.i4.469

13. Chaudhary R, Saadin K, Bliden KP, Harris WS, Dinh B, Sharma T, Tantry US, Gurbel PA. Risk factors associated with plasma omega-3 fatty acid levels in patients with suspected coronary artery disease. Prostaglandins Leukot Essent Fatty Acids. 2016 Oct; 113:40-45 Epub 2016 Aug 18 PMID: 27720039 DOI: 10.1016/j.plefa.2016.08.009

12. Garg J, Chaudhary R, Palaniswamy C, Shah N, Krishnamoorthy P, Bozorgnia B, Natale A. Cryoballoon versus Radiofrequency Ablation for Atrial Fibrillation: A Meta-analysis of 16 Clinical Trials. J Atr Fibrillation. 2016 Oct-Nov; 9 (3):1429 Epub 2016 Oct 31 PMID: 28496925 PMCID: 5368545 DOI: 10.4022/jafib.1429

11. Shah N, Chaudhary R, Mehta K, Agarwal V, Garg J, Freudenberger R, Jacobs L, Cox D, Kern KB, Patel N. Therapeutic Hypothermia and Stent Thrombosis: A Nationwide Analysis. JACC Cardiovasc Interv. 2016 Sep 12; 9 (17):1801-11 PMID: 27609254 DOI: 10.1016/j.jcin.2016.06.052

10. Chaudhary R, Bliden KP, Garg J, Mohammed N, Tantry U, Mathew D, Toth PP, Franzese C, Gesheff M, Pandya S, Gurbel P. Statin therapy and inflammation in patients with diabetes treated with high dose aspirin. J Diabetes Complications. 2016 Sep-Oct; 30 (7):1365-70 Epub 2016 May 10 PMID: 27237049 DOI: 10.1016/j.jdiacomp.2016.05.002

9. Garg J, Chaudhary R, Krishnamoorthy P, Palaniswamy C, Shah N, Bozorgnia B, Natale A. Safety and efficacy of oral factor-Xa inhibitors versus Vitamin K antagonist in patients with non-valvular atrial fibrillation: Meta-analysis of phase II and III randomized controlled trials. Int J Cardiol. 2016 Sep 1; 218:235-239 Epub 2016 May 14 PMID: 27236121 DOI: 10.1016/j.ijcard.2016.05.059

8. Bliden KP, Chaudhary R, Lopez LR, Damrongwatanasuk R, Guyer K, Gesheff MG, Franzese CJ, Kaza H, Tantry US, Gurbel PA. Oxidized Low-Density Lipoprotein-beta2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease. Am J Cardiol. 2016 Sep 1; 118 (5):673-8 Epub 2016 June 15 PMID: 27401271 DOI: 10.1016/j.amjcard.2016.06.023

7. Chaudhary R, Garg J, Krishnamoorthy P, Shah N, Lanier G, Martinez MW, Freudenberger R. Ivabradine: Heart Failure and Beyond. J Cardiovasc Pharmacol Ther. 2016 Jul; 21 (4):335-43 Epub 2015 Dec 31 PMID: 26721645 DOI: 10.1177/1074248415624157

6. Bliden KP, Tantry US, Chaudhary R, Byun S, Gurbel PA. Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events. Expert Rev Cardiovasc Ther. 2016 Jul; 14 (7):779-91 Epub 2016 June 02 PMID: 27215735 DOI: 10.1080/14779072.2016.1188005

5. Bliden KP, Tantry US, Gesheff MG, Franzese CJ, Pandya S, Toth PP, Mathew DP, Chaudhary R, Gurbel PA. Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent Restenosis. J Interv Cardiol. 2016 Apr; 29 (2):168-78 Epub 2016 Jan 29 PMID: 26822493 DOI: 10.1111/joic.12277

4. Garg J, Chaudhary R, Krishnamoorthy P, Shah N, Bozorgnia B, Natale A. Safety and Efficacy of Uninterrupted Periprocedural Apixaban in Patients Undergoing Atrial Fibrillation Catheter Ablation: A Metaanalysis Of 1,057 Patients. J Atr Fibrillation. 2016 Apr-May; 8 (6):1368 Epub 2016 Apr 30 PMID: 27909496 PMCID: 5089471 DOI: 10.4022/jafib.1368

3. Chaudhary R, Bliden KP, Tantry US, Mohammed N, Mathew D, Gesheff MG, Franzese CJ, Gurbel PA. Association of weight gain with coronary artery disease, inflammation and thrombogenicity. J Thromb Thrombolysis. 2016 Apr; 41 (3):394-403 PMID: 26714821 DOI: 10.1007/s11239-015-1327-y

2. Garg J, Chaudhary R, Krishnamoorthy P, Shah N, Natale A, Bozorgnia B. Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients. Int J Cardiol 2016 Jan 15; 203:906-8 Epub 2015 Nov 30 PMID: 26618251 DOI: 10.1016/j.ijcard.2015.11.085

1. White LE, Chaudhary R, Moore LJ, Moore FA, Hassoun HT. Surgical sepsis and organ crosstalk: the role of the kidney. J Surg Res. 2011 May 15; 167 (2):306-15 Epub 2010 Dec 30 PMID: 21324390 PMCID: 3077465 DOI: 10.1016/j.jss.2010.11.923

Book Chapters

15. Kingsley T, Kirchoff RW, Chaudhary R. Cardiology in the World of Informatics, Big Data, and Machine Learning. In: eBook of Cardiology 2020.

14. Tantry US, Rout A, Chaudhary R, Gurbel PA. Antiplatelet Agent Choice and Platelet Function Testing in CKD. In: Kidney Disease in the Cardiac Catheterization Laboratory. Pp103-118. Published Springer Link, 2020.

13. Chaudhary R, Garg J, Lanier GM. Peripartum Cardiomyopathy. In: Color Atlas and Synopsis of Heart Failure. Chapter 13. McGraw-Hill Medical; 2018.

12. Shah M, Gupta R, Chaudhary R, Patel N, Lanier G. Tyrosine Kinase Inhibitors. In: Cardiotoxicity of Chemotherapeutic Agents. New York, New York: Nova Science Publishers; 2017. p. 177-192.

11. Chaudhary R, Mukhi N, Gupta R, Garg J, Carson P, Shah N, Lanier G. Topoisomerase-1 Inhibitors and Miscellaneous Drugs. In: Cardiotoxicity of Chemotherapeutic Agents. New York, New York: Nova Science Publishers; 2017. p. 193-204.

10. Agarwal N, Gupta R, Sharma A, Tandon R, Chaudhary R, Dusaj R, Lanier G. Immunotherapy. In: Cardiotoxicity of Chemotherapeutic Agents. New York, New York: Nova Science Publishers; 2017. p. 137-152.

9. Garg J, Shah M, Chaudhary R, Gupta R, Patel R, Lanier G. Hormonal Therapy. In: Cardiotoxicity of Chemotherapeutic Agents. New York, New York: Nova Science Publishers; 2017. p. 121-136.

8. Chaudhary R, Gupta R, Anand V, Sharma A, Sandhu G, Lanier G. Antitumor Antiobiotcs: Anthracyclines, a Mechanism of Cardiotoxicity. In: Cardiotoxicity of Chemotherapeutic Agents. New York, New York: Nova Science Publishers; 2017. p. 39-52.

7. Gupta R, Chaudhary R, Anand V, Sharma A, Sandhu G, Lanier G. Antitumor Antibiotics: Newer Anthracyclines. In: Cardiotoxicity of Chemotherapeutic Agents. New York, New York: Nova Science Publishers; 2017. p. 89-100.

6. Gupta R, Chaudhary R, Anand V, Sharma A, Sandhu G, Lanier G. Antitumor Antibiotics: Bleomycin and Mitoxantrone. In: Cardiotoxicity of Chemotherapeutic Agents. New York, New York: Nova Science Publishers; 2017. p. 33-38.

5. Chaudhary R, Gupta R, Anand V, Sharma A, Sandhu G, Lanier G. Antitumor Antibiotics: Anthracyclines, Cardiotoxicity and Associated Risk Factors. In: Cardiotoxicity of Chemotherapeutic Agents. New York, New York: Nova Science Publishers; 2017. p. 53-68.

4. Chaudhary R, Gupta R, Anand V, Sharma A, Sandhu G, Lanier G. Antitumor Antibiotics: Anthracyclines and Minimizing Cardiotoxicy. In: Cardiotoxicity of Chemotherapeutic Agents. New York, New York: Nova Science Publishers; 2017. p. 66-88.

3. Shah N, Garg J, Chaudhary R, Ahmad H, Patel N. Revascularization for Peripheral Arterial Disease (PAD): Endovascular Therapies. In: Peripheral Artery Disease (PAD): Risk Factors, Diagnosis and Emerging Treatments. New York, New York: Nova Science Publishers; 2016. p. 23-45.

2. Garg J, Chaudhary R, Shah N, Patel N, Ahmad H. Medical Management of Peripheral Artery Disease (PAD). In: Peripheral Artery Disease (PAD). Chapter 2. New York, New York: Nova Science Publishers; 2016. p. 23-45